文献速递骨肌MR

基于MRI自动分割模型与影像组学列线图预测肉瘤无进展生存期:初步多中心研究

Predicting progression-free survival in sarcoma using MRI-based automatic segmentation models and radiomics nomograms: a preliminary multicenter study.
PubMed 文献 · Skeletal Radiol · 2024-12-04

这项多中心回顾性研究纳入202例病理确诊肉瘤患者,用ROI-Net在轴位FS-T2WI上自动分割肿瘤,其中120例用于影像组学分析(96例开发组、24例验证组)。基于21个特征的影像组学标签可区分PFS较差的高危患者,结合瘤周水肿、转移和影像组学评分的列线图在300/600/900天的AUC分别为0.947、0.907、0.924。

要点

  • ROI-Net自动分割与专家标注一致性高,Dice系数0.820(0.791-0.848)。
  • 21个影像组学特征构成的标签可区分PFS较差的高危肉瘤患者。
  • 结合瘤周水肿、转移与影像组学评分的列线图预测PFS效能最佳。

核心结论

  • ROI-Net自动分割结果与专家标注高度一致,影像组学特征及联合列线图有潜力辅助预测肉瘤患者的无进展生存期。

研究设计与样本

  • 多中心回顾性研究,连续纳入202例病理确诊肉瘤患者,均具备治疗前轴位FS-T2WI并进入ROI-Net模型训练。
  • 其中120例具备治疗前轴位T1WI和横断面FS-T2WI并纳入影像组学分析,随机分为开发组96例和验证组24例。
  • 开发组采用LASSO Cox回归筛选影像组学特征,再结合显著临床特征用Cox回归构建列线图。

关键影像表现/征象

  • 原文未描述具体影像征象,仅报告基于FS-T2WI的自动分割及影像组学特征分析。

诊断标准与关键数值

  • ROI-Net分割的Dice系数为0.820(0.791-0.848)。
  • 基于21个特征的影像组学标签可区分PFS较差的高危患者。
  • 单因素Cox分析显示瘤周水肿、转移和影像组学评分与较差PFS相关并纳入列线图。
  • Radiomics-T1WI-Clinical模型表现最佳,300天、600天、900天的AUC分别为0.947、0.907、0.924。

临床应用与阅片要点

  • 阅片时需关注瘤周水肿和转移等与PFS相关的征象,并在报告中体现。
  • 影像组学评分与临床特征联合的列线图可作为预后评估的辅助参考。

局限性

  • 回顾性设计;影像组学验证组仅24例,样本量较小;为初步多中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Some sarcomas are highly malignant, associated with high recurrence despite treatment. This multicenter study aimed to develop and validate a radiomics signature to estimate sarcoma progression-free survival (PFS).

MATERIALS AND METHODS: The study retrospectively enrolled 202 consecutive patients with pathologically diagnosed sarcoma, who had pre-treatment axial fat-suppressed T2-weighted images (FS-T2WI), and included them in the ROI-Net model for training. Among them, 120 patients were included in the radiomics analysis, all of whom had pre-treatment axial T1-weighted and transverse FS-T2WI images, and were randomly divided into a development group (n = 96) and a validation group (n = 24). In the development cohort, Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression was used to develop the radiomics features for PFS prediction. By combining significant clinical features with radiomics features, a nomogram was constructed using Cox regression.

RESULTS: The proposed ROI-Net framework achieved a Dice coefficient of 0.820 (0.791-0.848). The radiomics signature based on 21 features could distinguish high-risk patients with poor PFS. Univariate Cox analysis revealed that peritumoral edema, metastases, and the radiomics score were associated with poor PFS and were included in the construction of the nomogram. The Radiomics-T1WI-Clinical model exhibited the best performance, with AUC values of 0.947, 0.907, and 0.924 at 300 days, 600 days, and 900 days, respectively.

CONCLUSION: The proposed ROI-Net framework demonstrated high consistency between its segmentation results and expert annotations. The radiomics features and the combined nomogram have the potential to aid in predicting PFS for patients with sarcoma.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu N, Niu F, Fan S, et al. Predicting progression-free survival in sarcoma using MRI-based automatic segmentation models and radiomics nomograms: a preliminary multicenter study. Skeletal Radiol. 2024. PMID: 39630238. doi:10.1007/s00256-024-04837-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。